Skip to Main Content

Browse issues

Open Forum Infectious Diseases Cover Image for Volume 10, Issue 5
Volume 10, Issue 5
May 2023
EISSN 2328-8957

Volume 10, Issue 5, May 2023

Major Articles

Julie A Amendola and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad214, https://doi.org/10.1093/ofid/ofad214
Laura Lodolo and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad212, https://doi.org/10.1093/ofid/ofad212

The opt-out approach to infectious diseases testing is a recommended strategy to increase diagnosis and prevention of disease. We engaged stakeholders within jail healthcare to understand barriers and facilitators to the implementation of opt-out for vaccination in jails.

Selin Somersan-Karakaya and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad211, https://doi.org/10.1093/ofid/ofad211

In a post hoc analysis of hospitalized patients with COVID-19, immunocompromised patients were more frequently seronegative and had higher baseline viral loads. In both immunocompromised and overall study patients, casirivimab plus imdevimab reduced viral load and mechanical ventilation or death without new safety findings.

Yohhei Hamada and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad228, https://doi.org/10.1093/ofid/ofad228

Tuberculosis-specific skin tests have been shown to be similar in accuracy to interferon γ release assays. Our systematic review found that tuberculosis-specific skin tests are similar in safety to tuberculin skin tests and are mostly associated with mild injection site reactions.

Katia J Bruxvoort and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad219, https://doi.org/10.1093/ofid/ofad219

Among 79,302 adults with a positive latent tuberculosis infection (LTBI) test from 2009-2018, only 33% were prescribed treatment and 19% completed treatment. Additional efforts are needed to increase treatment prescription and completion for patients with LTBI

ID Teaching Cases

Jacob Scribner and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad213, https://doi.org/10.1093/ofid/ofad213

A 78-year old man presented one month after a tick bite with fever and lab findings consistent with hemophagocytic lymphohistiocytosis. Morulae were visualized in the bone marrow biopsy and serum PCR confirmed Anaplasma phagocytophilum. He improved on doxycycline and steroids.

Perspectives

Alya Heirali and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad195, https://doi.org/10.1093/ofid/ofad195

In this viewpoint article we define terminology to describe the bidirectional interactions between the microbiome and medical interventions. Pharmacomicrobiomics describes the unidirectional effects of microbiomes on bioavailability and bioactivity of drugs. Here we define pharmacoecology as the effects of medical interventions on microbiome composition and function.

Major Articles

Maryam Khan and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad108, https://doi.org/10.1093/ofid/ofad108
Melissa Pender and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad184, https://doi.org/10.1093/ofid/ofad184

Clostridioides difficile (CD) is commonly detected in a gastrointestinal multiplex molecular panel. Alternative testing yielded discordant results in a significant proportion, yet treatment was common. CD results in molecular panels should be interpreted with caution in the setting of low pretest probability.

Mamadou Saliou Kalifa Diallo and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad216, https://doi.org/10.1093/ofid/ofad216

The overall age-standardized SARS-CoV-2 IgG seroprevalence against spike and nucleocapsid proteins was 71.57% in Guinea and 74.71% in Cameroon after successive COVID-19 waves, including the Omicron wave from early 2022. Seroprevalence increased with age categories reaching 84% among persons >40 years.

Abinash Virk and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad161, https://doi.org/10.1093/ofid/ofad161

COVID-19 mRNA vaccination was associated with lower risk of COVID-19, including in those with prior COVID-19. Vaccination should be encouraged for those with remote prior infection, especially as new variants emerge and variant-specific booster vaccines become available.

Lucinda J Van Anglen and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad173, https://doi.org/10.1093/ofid/ofad173

C/T was successfully used in patients with a variety of serious infections, significant comorbidities, and a high prevalence of resistant pathogens in the outpatient setting.

Christian Ruiz and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad186, https://doi.org/10.1093/ofid/ofad186

The modified Dundee classification has recently been validated as the first scoring tool for non-purulent skin and soft tissue infections. This descriptive study uniquely applies this classification scheme toward optimizing antimicrobial stewardship and ultimately patient care.

Lindsay R Grant and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad192, https://doi.org/10.1093/ofid/ofad192
Fatimah S Dawood and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad204, https://doi.org/10.1093/ofid/ofad204
Shelley S Magill and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad218, https://doi.org/10.1093/ofid/ofad218

Among 736 US children and young adults with sepsis, 83% had community-onset sepsis. Most patients had underlying conditions, recent healthcare interactions were common, and age group–related differences were observed, suggesting opportunities to improve early recognition and clinical intervention.

Robert A Kozak and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad190, https://doi.org/10.1093/ofid/ofad190
Allison Chan and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad194, https://doi.org/10.1093/ofid/ofad194

Outbreaks of multidrug-resistant organisms linked to environmental reservoirs can be difficult to detect, which can result in persistent transmission for years. We describe an outbreak linked to intensive care unit sink drains in an acute care hospital.

Matthew Kaczynski and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad197, https://doi.org/10.1093/ofid/ofad197

In this study, we report differences in the willingness to enroll into inpatient COVID-19 clinical trials when invited among various patient populations. Our findings underscore the need for tailored and inclusive recruitment strategies to achieve diverse clinical trial enrollment.

Adam T Ladzinski and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad206, https://doi.org/10.1093/ofid/ofad206
Fatimah S Dawood and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad168, https://doi.org/10.1093/ofid/ofad168
Allison Avrich Ciesla and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad187, https://doi.org/10.1093/ofid/ofad187

Individuals with 1 or 2 monovalent mRNA COVID-19 booster doses were less likely to have symptomatic SARS-CoV-2 infection compared to those without booster doses, during the BA.2/BA.2.12.1 and BA.4/BA.5 predominant subvariant periods.

Dima Kabbani and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad200, https://doi.org/10.1093/ofid/ofad200
Jessica K DeMartino and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad203, https://doi.org/10.1093/ofid/ofad203

In this real-world study, nearly half of Medicare beneficiaries experienced a respiratory syncytial virus (RSV)–related complication within 1 month of RSV diagnosis. Presence of complications/comorbidities of interest pre–RSV diagnosis predicted a higher risk of having a different complication following diagnosis.

Benjamin Coleman and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad208, https://doi.org/10.1093/ofid/ofad208

In people with HIV and toxoplasmic encephalitis who demonstrate immune reconstitution while receiving antiretroviral therapy, contrast enhancement of magnetic resonance imaging lesions can persist for years following clinical improvement. Such persistence may not indicate active disease requiring therapy.

Gregory L Damhorst and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad226, https://doi.org/10.1093/ofid/ofad226
Jose R Castillo-Mancilla and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad230, https://doi.org/10.1093/ofid/ofad230
Jodian A Pinkney and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad201, https://doi.org/10.1093/ofid/ofad201

In our study, pregnancy, low vaccine confidence, and government mistrust were associated with a lower likelihood of COVID-19 vaccination among reproductive-aged women in Jamaica.

Hadil Onallah and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad221, https://doi.org/10.1093/ofid/ofad221
Masahiro Shirata and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad222, https://doi.org/10.1093/ofid/ofad222
Shyam Sundar and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad231, https://doi.org/10.1093/ofid/ofad231

Oral miltefosine is the first-line treatment for post–kala-azar dermal leishmaniasis in South Asia. This study assessed safety and effectiveness of miltefosine. The cure rate was 76%; however, a significant number of patients developed ocular complications.

Ofer Perzon and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad238, https://doi.org/10.1093/ofid/ofad238
Brandie DePaoli Taylor and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad220, https://doi.org/10.1093/ofid/ofad220

Prenatal Neisseria gonorrhoeae may increase the odds of preterm preeclampsia and preterm delivery. Even with screening and treatment, our study and the work of others show that gonorrhea may still negatively impact pregnancy health.

Paul Feuerstadt and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad171, https://doi.org/10.1093/ofid/ofad171
Chris Chavtur and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad202, https://doi.org/10.1093/ofid/ofad202

Posttreatment Plasmodium 18S ribosomal RNA molecular diagnostic data were assessed from multiple controlled human malaria infection studies to ascertain the clearance kinetics of this increasingly used biomarker. All participants showed complete clearance by 7 days after treatment initiation.

Review Articles

Mayar Al Mohajer and Todd Lasco
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad182, https://doi.org/10.1093/ofid/ofad182

Blood culture contamination is associated with unnecessary antibiotic use and hospital cost. Blood culture diversion techniques have been implemented with varying methods and results. This literature review highlights the need for a meta-analysis to inform providers about the optimal technique.

Flaminia Olearo and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad246, https://doi.org/10.1093/ofid/ofad246

In this systematic review and meta-analysis, we found no difference in treatment failure for prosthetic joint infections with shorter compared to longer antibiotic treatment, irrespective of the type of surgical procedure (debridement, antibiotics, and implant retention vs 1- or 2-stage exchange arthroplasty).

Brief Reports

Yannis Lassoued and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad188, https://doi.org/10.1093/ofid/ofad188

Since October 2022, an increase in invasive Group A streptococcal (iGAS) infections has been reported. In this 15-year study we showed that this increase was concomitant with intense respiratory viruses' outbreak. Physicians should be aware of this increased risk of pediatric iGAS infections.

Daniel A Sweeney and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad205, https://doi.org/10.1093/ofid/ofad205
Tjitske S R van Engelen and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad215, https://doi.org/10.1093/ofid/ofad215

Patients clinically suspected of community-acquired pneumonia were randomized between ultra-low-dose chest computed tomography (ULDCT, 261 patients) and chest radiograph (CXR, 231 patients). We did not find evidence that performing ULDCT instead of CXR affects antibiotic treatment policy or patient outcomes.

Isabelle de Malliard and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad217, https://doi.org/10.1093/ofid/ofad217
Paula Saá and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad253, https://doi.org/10.1093/ofid/ofad253
Woody Sorey and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad254, https://doi.org/10.1093/ofid/ofad254
Mya Tran and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad236, https://doi.org/10.1093/ofid/ofad236
Jana L Jacobs and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad278, https://doi.org/10.1093/ofid/ofad278

Response to Letter to the Editor

Nathaniel M Lewis and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad185, https://doi.org/10.1093/ofid/ofad185

Correspondence

Rattanaporn Mahatanan and HeeEun Kang
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad207, https://doi.org/10.1093/ofid/ofad207
Kyle C Molina and others
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad210, https://doi.org/10.1093/ofid/ofad210
Amnuay Kleebayoon and Viroj Wiwanitkit
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad183, https://doi.org/10.1093/ofid/ofad183

Correction

Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad249, https://doi.org/10.1093/ofid/ofad249
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad250, https://doi.org/10.1093/ofid/ofad250
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad252, https://doi.org/10.1093/ofid/ofad252
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad251, https://doi.org/10.1093/ofid/ofad251
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad260, https://doi.org/10.1093/ofid/ofad260
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad259, https://doi.org/10.1093/ofid/ofad259
Open Forum Infectious Diseases, Volume 10, Issue 5, May 2023, ofad261, https://doi.org/10.1093/ofid/ofad261
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close